ClinicalTrials.gov
public full text
Public Domain
TXA and Corona Virus 2019 (COVID19) in Outpatients
A controlled trial of the drug tranexamic acid (TXA) in outpatients who were recently diagnosed with COVID-19. It is hypothesized that TXA will reduce the infectivity and virulence of the virus.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Pre-Release VIVITROL for Opioid Dependent Inmates#1058822
- Technology Enhanced Community Health Nursing (TECH-N) Study#1031998
- Study of Enahnced External Counterpulsation to Treat Coronary Heart Disease#968669
- Combined IV and Topical TXA in Major Spine Surgery#884370
- Colchicine Plus Phenolic Monoterpenes to Treat COVID-19#846027
Record · ID 824957
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive